Computational Modeling Predicts Benefits of Proefferocytic Therapy in Human Atherosclerosis


Journal article


K. Jarr, K. Palm, G. Pasterkamp, M. Mokry, N. Leeper
Circulation, 2025


Cite

Cite

APA   Click to copy
Jarr, K., Palm, K., Pasterkamp, G., Mokry, M., & Leeper, N. (2025). Computational Modeling Predicts Benefits of Proefferocytic Therapy in Human Atherosclerosis. Circulation. https://doi.org/10.1161/CIRCULATIONAHA.124.072676


Chicago/Turabian   Click to copy
Jarr, K., K. Palm, G. Pasterkamp, M. Mokry, and N. Leeper. “Computational Modeling Predicts Benefits of Proefferocytic Therapy in Human Atherosclerosis.” Circulation (2025).


MLA   Click to copy
Jarr, K., et al. “Computational Modeling Predicts Benefits of Proefferocytic Therapy in Human Atherosclerosis.” Circulation, 2025, doi:10.1161/CIRCULATIONAHA.124.072676.


BibTeX   Click to copy

@article{k2025a,
  title = {Computational Modeling Predicts Benefits of Proefferocytic Therapy in Human Atherosclerosis},
  year = {2025},
  journal = {Circulation},
  doi = {10.1161/CIRCULATIONAHA.124.072676},
  author = {Jarr, K. and Palm, K. and Pasterkamp, G. and Mokry, M. and Leeper, N.}
}